Recent News

• 08.12.2025 - Daxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now Available
• 08.07.2025 - Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System
• 07.22.2025 - Daxor’s Blood Volume Analysis Technology Accelerates Market Penetration with Three New Facility Adoptions
• 05.14.2025 - Daxor Announces Duke University Study on Blood Volume Analysis in Heart Failure Published in American Heart Journal
• 05.13.2025 - Daxor’s Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare Systems

Recent Filings

• 08.07.2025 - 8-K Current report
• 08.07.2025 - EX-99.1 EX-99.1
• 07.24.2025 - N-2/A Registration statement for closed-end investment companies
• 07.24.2025 - N-CEN/A Annual Report for Registered Investment Companies
• 07.24.2025 - N-CEN/A Annual Report for Registered Investment Companies
• 07.01.2025 - 8-K Current report
• 06.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.26.2025 - 4 Statement of changes in beneficial ownership of securities